Abstract:Background Lewy body disorders (LBD), encompassing Parkinson disease (PD), PD dementia (PDD), and dementia with Lewy bodies (DLB), are characterized by alpha-synuclein pathology but often are accompanied by Alzheimer's disease (AD) neuropathological change (ADNC). The medial temporal lobe (MTL) is a primary locus of tau accumulation and associated neurodegeneration in AD. However, it is unclear the extent to which AD copathology in LBD (LBD/AD + ) contributes to MTL-specific patterns of degeneration. We employ a MTL subregional segmentation strategy of T1-weighted (T1w) MRI in biomarker-supported or autopsy-confirmed LBD and LBD/AD + to investigate the anatomic consequences of co-occurring LBD/AD + pathology on neurodegeneration. Methods We studied 167 individuals with clinical diagnoses of LBD (PD, n = 124 (74.3 %); PDD, n = 11 (6.6 %); DLB, n = 32 (19.2 %)) with available T1w MRI and AD biomarkers or autopsy evidence of ADNC. Individuals were further biologically classified as LBD/AD + based on hierarchical evidence of ADNC pathology: 1) AD "intermediate" or "high" by ABC neuropathologic criteria (n = 39 (23.4 %)); 2) positive amyloid PET (n = 2 (1.2 %)); or 3) CSF β-amyloid 1-42 < 185.7 pg/mL n = 126 (75.4 %)). The T1 Automated Segmentation of Hippocampal Subfields (ASHS) pipeline was used to compute volume and thickness measurements of MTL subregions in LBD/AD- and LBD/AD + . Linear regression tested the association of AD copathology and subregion volume/thickness, covarying for age and sex, and intracranial volume for volume measurements. Secondary analyses correlated MTL subregional volume/thickness with cognition and neuropathology. Results LBD/AD + had decreased volume/thickness compared to LBD/AD- in all MTL subregions except posterior hippocampus. The greatest effect sizes were seen in Brodmann Area 35 (BA35) (Cohen's d = 0.62, p = 0.002, β = 0.107 ± 0.034), and entorhinal cortex (ERC) (Cohen's d = 0.56, p = 0.006, β = 0.088 ± 0.031). Smaller differences were seen in the parahippocampal cortex (PHC) (Cohen's d = 0.5, p = 0.012, β = 0.082 ± 0.033), BA36 (Cohen's d = 0.47, p = 0.021, β = 0.090 ± 0.039) and anterior hippocampus (Cohen's d = 0.45, p = 0.029, β = 111.790 ± 50.595). Verbal memory scores positively correlated with volume/thickness in anterior and posterior hippocampus, BA35, ERC and PHC, while visuospatial memory positively correlated only in BA35. In the subset of participants with autopsy, lower ERC volume was associated with a higher tau load in ERC (adjusted odds ratio 0.013, 95 % CI [0.0002, 0.841], uncorrected p = 0.041). Conclusions Relative to LBD/AD-, LBD/AD + has greater T1w MRI evidence of atrophy in multiple MTL subregions. Atrophy in MTL subregions associates with memory performance and tau pathological load. The observed pattern of atrophy largely follows expectation from AD Braak stages, except for posterior hippocampus. Longitudinal studies are needed to validate the hypothesized spread of neurodegeneration.

Volumetric GWAS of Medial Temporal Lobe Structures Identifies an ERC1 Locus Using ADNI High-Resolution T2-weighted MRI Data.

O5‐07‐05: GWAS OF HIPPOCAMPAL SUBFIELD AND NEIGHBORING CORTICAL STRUCTURE VOLUMES IDENTIFIES AN ERC1 LOCUS USING ADNI HIGH‐RESOLUTION MRI DATA

Mining Outcome-Relevant Brain Imaging Genetic Associations Via Three-Way Sparse Canonical Correlation Analysis in Alzheimer'S Disease

Identification of novel associations of candidate loci with Alzheimer's disease by leveraging the shared genetic basis with hippocampal volume

GWAS-Linked Loci and Neuroimaging Measures in Alzheimer’s Disease

Genetic Association of HLA Gene Variants with MRI Brain Structure in Alzheimer’s Disease

Brain-wide Genome-Wide Colocalization Study for Integrating Genetics, Transcriptomics and Brain Morphometry in Alzheimer's Disease

Revealing the Correlations Between Brain Cortical Characteristics and Susceptibility Genes for Alzheimer Disease: a Cross-Sectional Study.

Genome-wide Association Study of Hippocampal Atrophy Rate in Non-Demented Elders

TARGETED MYELINATION PATHWAY-BASED GENE ANALYSIS IDENTIFIES RXRA ASSOCIATED WITH WHITE MATTER CHANGES IN MILD COGNITIVE IMPAIRMENT AND ALZHEIMER'S DISEASE

Medial temporal lobe (MTL) – default‐mode network (DMN) functional connectivity disruption in the early stages of the progression of Alzheimer’s disease in a multimodal ADNI3 MP‐RAGE and EPI‐BOLD Advanced cohort

Voxelwise genome-wide association study (vGWAS)

Medial temporal lobe (MTL) – default‐mode network (DMN) functional connectivity disruption in the early stages of the progression of Alzheimer’s disease in a multimodal ADNI3 MP‐RAGE and EPI‐BOLD Basic cohort

Multivariate genome wide association and network analysis of subcortical imaging phenotypes in Alzheimer's disease

Effects of HLA - DRB1 / DQB1 Genetic Variants on Neuroimaging in Healthy, Mild Cognitive Impairment, and Alzheimer’s Disease Cohorts

Novel Genomic Loci Shape Two Neuroanatomical Dimensions of AD in Non‐demented Populations

Multivariate GWAS of Alzheimer's disease CSF biomarker profiles implies GRIN2D in synaptic functioning

P-020: Regional Gray Matter Reductions in Alzheimer’s Dementia and Amnestic Mild Cognitive Impairment: Preliminary Findings from the Alzheimer’s Disease Neuroimaging Initiative Using Voxel-Based Morphometry

Posterior hippocampal sparing in Lewy body disorders with Alzheimer's copathology: An in vivo MRI study

Hippocampal Transcriptome-Wide Association Study and Neurobiological Pathway Analysis for Alzheimer's Disease.

Identifying Candidate Genetic Associations with MRI-Derived AD-Related ROI Via Tree-Guided Sparse Learning